La catena delle opzioni mostra i dati chiave delle opzioni azionarie di ABC arbitrage a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per ABC arbitrage..

ABC arbitrage (OTC:ABCCF) Azioni, Catena delle Opzioni

ABC arbitrage SA is a France-based company engaged in the design of arbitration strategies in European and American financial markets. The group conducts two types of arbitrage strategies, including arbitrage without market risks, which exploits opportunities that are independent of directional or event risks, and arbitrage with market risks, where various risks involved are systematically identified and hedged using appropriate instruments. ABC Arbitrage also provides asset management services to institutional clients and advisory services for third-party institutional clients or qualified investors. The company's funds are managed by ABC Arbitrage Asset Management.

ABC arbitrage SA

PSQ Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSQH#NYSE">PSQH</a>) FY2025 Revenue expected to be more than $46.00M vs $42.23M Est

News

Guidance

PSQH

PSQ Holdings FY2025  Revenue expected to be more than $46.00M vs $42.23M Est

WIIM

IOVA

Iovance Biotherapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results.

AbCellera Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABCL#NASDAQ">ABCL</a>) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $4.24 million which missed the analyst consensus estimate of $7.53 million by 43.74 percent. This is a 57.45 percent decrease over sales of $9.95 million the same period last year.

Earnings

Earnings Misses

ABCL

AbCellera Biologics Q1 EPS $(0.14), Inline, Sales $4.24M Miss $7.53M Estimate

Mitek Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITK#NASDAQ">MITK</a>) affirms FY2025 sales outlook from $170.00 million-$180.00 million to $170.00 million-$180.00 million vs $175.51 million estimate.

MITK

Mitek Systems Affirms FY2025 Sales Guidance of $170.00M-$180.00M vs $175.51M Est

IBEX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBEX#NASDAQ">IBEX</a>) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.72 by 13.89 percent. This is a 17.14 percent increase over earnings of $0.70 per share from the same period last year. The company reported quarterly sales of $140.74 million which beat the analyst consensus estimate of $131.25 million by 7.23 percent. This is a 10.99 percent increase over sales of $126.80 million the same period last year.

Earnings Beats

IBEX

IBEX Q3 Adj. EPS $0.82 Beats $0.72 Estimate, Sales $140.74M Beat $131.25M Estimate

Sutro Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRO#NASDAQ">STRO</a>) reported quarterly losses of $(0.91) per share which missed the analyst consensus estimate of $(0.71) by 28.17 percent. This is a 4.21 percent increase over losses of $(0.95) per share from the same period last year. The company reported quarterly sales of $17.40 million which beat the analyst consensus estimate of $11.61 million by 49.85 percent. This is a 33.76 percent increase over sales of $13.01 million the same period last year.

STRO

Sutro Biopharma Q1 EPS $(0.91) Misses $(0.71) Estimate, Sales $17.40M Beat $11.61M Estimate

PSQ Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSQH#NYSE">PSQH</a>) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.31) by 67.74 percent. This is a 77.27 percent increase over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $6.75 million which missed the analyst consensus estimate of $6.83 million by 1.19 percent. This is a 94.75 percent increase over sales of $3.47 million the same period last year.

PSQ Holdings Q1 EPS $(0.10) Beats $(0.31) Estimate, Sales $6.75M Miss $6.83M Estimate

Kingsway Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFS#NYSE">KFS</a>) reported quarterly losses of $(0.13) per share. This is a 44.44 percent decrease over losses of $(0.09) per share from the same period last year. The company reported $28.35 million in sales this quarter. This is a 8.20 percent increase over sales of $26.20 million the same period last year.

Kingsway Financial Servs Q1 EPS $(0.13) Down From $(0.09) YoY, Sales $28.35M Up From $26.20M YoY

CARG

CarGurus shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results and issued Q2 adjusted EPS guidance above estimates.

Nelnet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNI#NYSE">NNI</a>) reported quarterly earnings of $2.39 per share which beat the analyst consensus estimate of $1.92 by 24.48 percent. This is a 32.04 percent increase over earnings of $1.81 per share from the same period last year. The company reported quarterly sales of $398.49 million which beat the analyst consensus estimate of $393.27 million by 1.33 percent. This is a 3.40 percent increase over sales of $385.38 million the same period last year.

Nelnet Q1 Adj. EPS $2.39 Beats $1.92 Estimate, Sales $398.49M Beat $393.27M Estimate

KLXE

KLX Energy Services shares are trading lower after the company reporter worse-than-expected Q1 financial results

Cantaloupe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTLP#NASDAQ">CTLP</a>) lowers FY2025 sales outlook from $308.00 million-$322.00 million to $302.00 million-$308.00 million vs $309.90 million estimate.

CTLP

Cantaloupe Lowers FY2025 Sales Guidance from $308.00M-$322.00M to $302.00M-$308.00M vs $309.90M Est

Sweetgreen shares are trading lower after the company reported Q1. Also, the company cut its FY25 sales guidance below estimates.

Alamo Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALG#NYSE">ALG</a>) reported quarterly earnings of $2.65 per share which beat the analyst consensus estimate of $2.27 by 16.74 percent. This is a 1.85 percent decrease over earnings of $2.70 per share from the same period last year. The company reported quarterly sales of $390.95 million which missed the analyst consensus estimate of $391.06 million by 0.03 percent. This is a 8.14 percent decrease over sales of $425.59 million the same period last year.

Alamo Group Q1 Adj. EPS $2.65 Beats $2.27 Estimate, Sales $390.95M Miss $391.06M Estimate

Abacus Life (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABL#NASDAQ">ABL</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.16 by 12.5 percent. This is a 63.64 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $44.14 million which beat the analyst consensus estimate of $39.76 million by 11.02 percent. This is a 105.42 percent increase over sales of $21.49 million the same period last year.

Abacus Life Q1 Adj. EPS $0.18 Beats $0.16 Estimate, Sales $44.14M Beat $39.76M Estimate

AVPT

AvePoint shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 sales guidance above estimates. Also, the company raised its FY25 sales guidance above estimates.

Rackspace Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXT#NASDAQ">RXT</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $665.40 million which beat the analyst consensus estimate of $658.18 million by 1.10 percent. This is a 3.68 percent decrease over sales of $690.80 million the same period last year.

Rackspace Tech Q1 Adj. EPS $(0.06) Beats $(0.08) Estimate, Sales $665.40M Beat $658.18M Estimate

DCGO

DocGo shares are trading lower after the company reported worse-than-expected Q1 financial results.

ZimVie (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZIMV#NASDAQ">ZIMV</a>) affirms FY2025 Adj EPS guidance from $0.80-$0.95 to $0.80-$0.95 vs $0.84 analyst estimate. Affirms FY2025 sales outlook from $445.00 million-$460.00 million to $445.00 million-$460.00 million vs $450.35 million estimate.

ZIMV

ZimVie Affirms FY2025 Adj EPS Guidance of $0.80-$0.95 vs $0.84 Est; Affirms FY2025 Sales Guidance of $445.00M-$460.00M vs $450.35M Est

Montauk Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTK#NASDAQ">MNTK</a>) reported quarterly sales of $42.60 million which beat the analyst consensus estimate of $42.40 million by 0.48 percent. This is a 9.84 percent increase over sales of $38.79 million the same period last year.

Comments

ABC arbitrage

ABC arbitrage (ABCCF) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO